Edition:
United States

People: Alere Inc (ALR_pb.N)

ALR_pb.N on New York Stock Exchange

389.50USD
18 Aug 2017
Change (% chg)

$-0.50 (-0.13%)
Prev Close
$390.00
Open
$389.50
Day's High
$389.50
Day's Low
$389.50
Volume
100
Avg. Vol
1,360
52-wk High
$400.00
52-wk Low
$292.00

Bridgen, John 

Dr. John Bridgen, Ph.D. serves as Senior Vice President - Business Development of the Company. He served as our Vice President, Strategy from September 2005 to June 2006. Dr. Bridgen joined our Company in September 2002, upon our acquisition of Wampole Laboratories, LLC. Dr. Bridgen served as President of Wampole from August 1984 until September 2005. Prior to joining Wampole, Dr. Bridgen had global sales and marketing responsibility for the hematology and immunology business units of Ortho Diagnostic Systems Inc., a Johnson & Johnson company.

Basic Compensation

Total Annual Compensation, USD 553,600
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 332,985
Fiscal Year Total, USD 886,585

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Gregg Powers

289,965

Namal Nawana

8,574,310

James Hinrichs

2,868,380

Daniella Cramp

2,113,670

Sanjay Malkani

2,217,100

Avi Pelossof

2,114,960
As Of  30 Dec 2016